Fig. 3From: A robust multiplex immunoaffinity mass spectrometry assay (PromarkerD) for clinical prediction of diabetic kidney diseaseMethod comparison. Scatter plot of the correlation between the original immunodepletion (ImDe) method and the new immunoaffinity (IAMS) method PromarkerD risk scores. Generated after individual biomarker Bland–Altman analyses between the methods. Slope of the line of equality is 1Back to article page